None
Quote | IVERIC bio Inc. (NYSE:ISEE)
Last: | $ |
---|---|
Change Percent: | -1.83% |
Open: | $7.17 |
Close: | $6.97 |
High: | $7.44 |
Low: | $6.91 |
Volume: | 448,615 |
Last Trade Date Time: | 02/12/2020 04:41:37 pm |
News | IVERIC bio Inc. (NYSE:ISEE)
2023-08-16 12:41:31 ET Summary Astellas has closed its Iveric bio, Inc. deal in July and reported JPY 375Bn in quarterly sales in Q1. The company's earnings power and asset factors are bullish, but valuation factors are keeping me neutral. From this, I am closely watching the ...
Astellas Completes Acquisition of Iveric Bio PR Newswire TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura , "Astellas") today announced that it has successfully completed the acquisit...
Message Board Posts | IVERIC bio Inc. (NYSE:ISEE)
Subject | By | Source | When |
---|---|---|---|
MomentumIts gaining | TheFinalCD | investorshub | 04/30/2023 10:09:39 PM |
$ISEE MomentumIts gaining last trade up | Pedro2004 | investorshub | 04/30/2023 4:25:49 PM |
$ISEE The now | crudeoil24 | investorshub | 04/30/2023 10:41:12 AM |
MomentumIts gaining | ztek | investorshub | 04/23/2023 12:05:12 AM |
$ISEE bears are running | ztek | investorshub | 04/22/2023 1:02:20 AM |
News, Short Squeeze, Breakout and More Instantly...
Astellas Completes Acquisition of Iveric Bio PR Newswire TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura , "Astellas") today announced that it has successfully completed the acquisit...
Shares of IVERIC bio, Inc. (NASDAQ: ISEE) traded at a new 52-week high today and are currently trading at $39.73. So far today, approximately 1.78M shares have been exchanged, as compared to an average 30-day volume of 5.04M shares. IVERIC bio, Inc., a biopharmaceutical company, discovers and...
IVERIC bio, Inc. (NASDAQ: ISEE) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 1.93% on the day to $38.77. IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal disease...